As CGT Struggles To Scale, FDA’s New Designation Could Smooth Post-Approval Pivots
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The FDA has given a new designation that could help with post-approval changes for certain technologies. This designation, called Advanced Manufacturing Technology, has been received by Ori Biotech's IRO platform. The move may aid in addressing scaling issues for cell and gene therapies.